These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 18500382)

  • 1. Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA).
    Docherty JR
    Br J Pharmacol; 2008 Jun; 154(3):606-22. PubMed ID: 18500382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system stimulants and sport practice.
    Avois L; Robinson N; Saudan C; Baume N; Mangin P; Saugy M
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i16-20. PubMed ID: 16799095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the use of stimulants in out-of-competition sport samples.
    Boghosian T; Mazzoni I; Barroso O; Rabin O
    J Anal Toxicol; 2011 Nov; 35(9):613-6. PubMed ID: 22080900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
    Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
    Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problems of the use of pseudoephedrine by athletes.
    Pokrywka A; Tszyrsznic W; Kwiatkowska DJ
    Int J Sports Med; 2009 Aug; 30(8):569-72. PubMed ID: 19382058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Adrenergic stimulation.
    Van Eenoo P; Delbeke FT
    Handb Exp Pharmacol; 2010; (195):227-49. PubMed ID: 20020368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulant doping agents used in Brazil: prevalence, detectability, analytical implications, and challenges.
    Pereira HM; Sardela VF
    Subst Use Misuse; 2014 Jul; 49(9):1098-114. PubMed ID: 24766455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unauthorized ingredients in "nootropic" dietary supplements: A review of the history, pharmacology, prevalence, international regulations, and potential as doping agents.
    Jędrejko K; Catlin O; Stewart T; Anderson A; Muszyńska B; Catlin DH
    Drug Test Anal; 2023 Aug; 15(8):803-839. PubMed ID: 37357012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects.
    Heuberger JAAC; Cohen AF
    Sports Med; 2019 Apr; 49(4):525-539. PubMed ID: 30411235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulants and doping in sport.
    Thevis M; Sigmund G; Geyer H; Schänzer W
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):89-105, ix. PubMed ID: 20122452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of Drugs Used as Stimulants.
    Docherty JR; Alsufyani HA
    J Clin Pharmacol; 2021 Aug; 61 Suppl 2():S53-S69. PubMed ID: 34396557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doping and musculoskeletal system: short-term and long-lasting effects of doping agents.
    Nikolopoulos DD; Spiliopoulou C; Theocharis SE
    Fundam Clin Pharmacol; 2011 Oct; 25(5):535-63. PubMed ID: 21039821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of caffeine levels in urine in different sports in relation to doping control before and after the removal of caffeine from the WADA doping list.
    Van Thuyne W; Delbeke FT
    Int J Sports Med; 2006 Sep; 27(9):745-50. PubMed ID: 16586337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs and sport. Research findings and limitations.
    Clarkson PM; Thompson HS
    Sports Med; 1997 Dec; 24(6):366-84. PubMed ID: 9421862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Stimulants and Narcotics by Liquid Chromatography-Tandem Mass Spectrometry and Gas Chromatography-Mass Spectrometry for Sports Doping Control.
    Ahrens BD; Kucherova Y; Butch AW
    Methods Mol Biol; 2016; 1383():247-63. PubMed ID: 26660193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and Development of the List of Prohibited Substances and Methods.
    Kinahan A; Budgett R; Mazzoni I
    Med Sport Sci; 2017; 62():39-54. PubMed ID: 28571027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine and other sympathomimetic stimulants: modes of action and effects on sports performance.
    Jones G
    Essays Biochem; 2008; 44():109-23. PubMed ID: 18384286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.